PMID: 11927833Apr 3, 2002Paper

Polymorphisms in the methylenetetrahydrofolate reductase gene were associated with both the efficacy and the toxicity of methotrexate used for the treatment of rheumatoid arthritis, as evidenced by single locus and haplotype analyses

Pharmacogenetics
Wako UranoN Kamatani

Abstract

5,10-Methylenetetrahydrofolate reductase (MTHFR), a key enzyme involved in folate metabolism, has two common polymorphisms that affect enzyme activity. The objective of this study was to examine whether there was a correlation between the genotype or haplotype of the MTHFR gene and the efficacy or toxicity of methotrexate (MTX) in the treatment of rheumatoid arthritis. MTX-treated rheumatoid arthritis patients (n = 106) were selected from outpatient clinics and used for a retrospective study to examine the correlation between genotypes or haplotypes concerning polymorphisms of the MTHFR gene, and the efficacy or toxicity of MTX. Estimation of the haplotype frequencies was performed by maximum likelihood estimation based on expectation maximization algorithm. Single locus analysis examining each locus separately showed that patients with 1298C were receiving significantly lower doses of MTX compared to patients without [P < 0.05, relative risk (RR) = 2.18, 95% confidence interval (CI) 1.17-4.06], while a higher rate of overall MTX toxicity was observed in patients with 677T than those without (P < 0.05, RR = 1.25, 95% CI 1.05-1.49). An estimation of haplotype frequencies showed that there was no 677T-1298C haplotype in the popul...Continue Reading

References

Mar 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·B N CronsteinR I Levin
Mar 1, 1988·Arthritis and Rheumatism·D E Furst, J M Kremer
Nov 3, 1983·The New England Journal of Medicine·J JolivetB A Chabner
Oct 28, 1997·American Journal of Medical Genetics·T ArinamiM Toru
Oct 28, 1998·Proceedings of the National Academy of Sciences of the United States of America·P J Bagley, J Selhub
Oct 27, 1999·Proceedings of the National Academy of Sciences of the United States of America·C F SkibolaG Morgan

❮ Previous
Next ❯

Citations

Jan 27, 2011·Zeitschrift für Rheumatologie·H Mühl, J Pfeilschifter
Aug 11, 2005·Current Oncology Reports·Joseph M Scandura
Apr 9, 2013·Immunologic Research·Zoltán SzekaneczLászló Nagy
Apr 15, 2005·Mutation Research·Thierry DervieuxBruce Neri
Aug 26, 2006·Nature Clinical Practice. Rheumatology·Bruce N Cronstein
Feb 9, 2012·Nature Reviews. Gastroenterology & Hepatology·Michael Camilleri
Aug 10, 2011·Nature Reviews. Rheumatology·Lesley Davila, Prabha Ranganathan
Apr 9, 2004·The New England Journal of Medicine·Ching-Hon PuiJames R Downing
May 6, 2008·The Journal of Infectious Diseases·David M ReifJames E Crowe
Oct 26, 2012·Omics : a Journal of Integrative Biology·José Cristian Plaza-PlazaMiguel Angel Calleja
Mar 3, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A ArgirisD E Heron
Sep 6, 2005·Pharmacogenetics and Genomics·Klaus R HerrlingerDerek P Jewell
Mar 16, 2006·Pharmacogenetics and Genomics·Yvette N MartinRichard M Weinshilboum
Jul 18, 2006·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Iris ScalaGeneroso Andria
Nov 19, 2004·Current Opinion in Hematology·Parinda A Mehta, Stella M Davies
Dec 7, 2011·Pharmacogenetics and Genomics·Kalliopi P SpyridopoulouPantelis G Bagos
Oct 14, 2004·Annals of the Rheumatic Diseases·B N Cronstein
Aug 15, 2006·Annals of the Rheumatic Diseases·J M Kremer
Apr 1, 2009·Therapeutic Advances in Musculoskeletal Disease·Paula I BurgosS Louis Bridges
Oct 31, 2006·BMC Cancer·Damali N MartinStefan Ambs
Jul 3, 2009·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Sachie InoueMayumi Mochizuki
Sep 1, 2004·Pharmacogenomics·Giuseppe Toffoli, Erika Cecchin
Oct 8, 2004·Pharmacogenomics·Maja Krajinovic, Albert Moghrabi
Dec 9, 2004·Pharmacogenomics·Gianfranco FerraccioliBarbara Tolusso
Jan 1, 2010·Pharmacogenomics and Personalized Medicine·Darren D O'Rielly, Proton Rahman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.